 | • レポートコード：MRC2-11QY01422 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒト凝固因子IXのグローバル市場について調査・分析したレポートです。種類別（AHGB、AHFB、その他）市場規模、用途別（病院、パーソナルクリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒト凝固因子IXの競争状況、市場シェア ・世界のヒト凝固因子IX市場：種類別市場規模 2015年-2020年（AHGB、AHFB、その他） ・世界のヒト凝固因子IX市場：種類別市場規模予測 2021年-2026年（AHGB、AHFB、その他） ・世界のヒト凝固因子IX市場：用途別市場規模 2015年-2020年（病院、パーソナルクリニック、その他） ・世界のヒト凝固因子IX市場：用途別市場規模予測 2021年-2026年（病院、パーソナルクリニック、その他） ・北米のヒト凝固因子IX市場分析：米国、カナダ ・ヨーロッパのヒト凝固因子IX市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒト凝固因子IX市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒト凝固因子IX市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒト凝固因子IX市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Grifols、Biogen、Octapharma、Baxter、Bayer、CSL、Novo Nordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Human Coagulation Factor IX Market
The global Human Coagulation Factor IX market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Coagulation Factor IX Scope and Market Size
Human Coagulation Factor IX market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Coagulation Factor IX market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Coagulation Factor IX market is segmented into
AHGB
AHFB
Others
Segment by Application, the Human Coagulation Factor IX market is segmented into
Hospital
Personal Clinic
Others
Regional and Country-level Analysis
The Human Coagulation Factor IX market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Coagulation Factor IX market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Coagulation Factor IX Market Share Analysis
Human Coagulation Factor IX market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Coagulation Factor IX business, the date to enter into the Human Coagulation Factor IX market, Human Coagulation Factor IX product introduction, recent developments, etc.
The major vendors covered:
Grifols
Biogen
Octapharma
Baxter
Bayer
CSL
Novo Nordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Pfizer
1 Study Coverage
1.1 Human Coagulation Factor IX Product Introduction
1.2 Market Segments
1.3 Key Human Coagulation Factor IX Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Coagulation Factor IX Market Size Growth Rate by Type
1.4.2 AHGB
1.4.3 AHFB
1.4.4 Others
1.5 Market by Application
1.5.1 Global Human Coagulation Factor IX Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Personal Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor IX Market Size, Estimates and Forecasts
2.1.1 Global Human Coagulation Factor IX Revenue 2015-2026
2.1.2 Global Human Coagulation Factor IX Sales 2015-2026
2.2 Global Human Coagulation Factor IX, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Coagulation Factor IX Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Coagulation Factor IX Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Coagulation Factor IX Competitor Landscape by Players
3.1 Human Coagulation Factor IX Sales by Manufacturers
3.1.1 Human Coagulation Factor IX Sales by Manufacturers (2015-2020)
3.1.2 Human Coagulation Factor IX Sales Market Share by Manufacturers (2015-2020)
3.2 Human Coagulation Factor IX Revenue by Manufacturers
3.2.1 Human Coagulation Factor IX Revenue by Manufacturers (2015-2020)
3.2.2 Human Coagulation Factor IX Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Coagulation Factor IX Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Coagulation Factor IX Revenue in 2019
3.2.5 Global Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Coagulation Factor IX Price by Manufacturers
3.4 Human Coagulation Factor IX Manufacturing Base Distribution, Product Types
3.4.1 Human Coagulation Factor IX Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Coagulation Factor IX Product Type
3.4.3 Date of International Manufacturers Enter into Human Coagulation Factor IX Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Coagulation Factor IX Market Size by Type (2015-2020)
4.1.1 Global Human Coagulation Factor IX Sales by Type (2015-2020)
4.1.2 Global Human Coagulation Factor IX Revenue by Type (2015-2020)
4.1.3 Human Coagulation Factor IX Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Coagulation Factor IX Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Coagulation Factor IX Sales Forecast by Type (2021-2026)
4.2.2 Global Human Coagulation Factor IX Revenue Forecast by Type (2021-2026)
4.2.3 Human Coagulation Factor IX Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Coagulation Factor IX Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Coagulation Factor IX Market Size by Application (2015-2020)
5.1.1 Global Human Coagulation Factor IX Sales by Application (2015-2020)
5.1.2 Global Human Coagulation Factor IX Revenue by Application (2015-2020)
5.1.3 Human Coagulation Factor IX Price by Application (2015-2020)
5.2 Human Coagulation Factor IX Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Coagulation Factor IX Sales Forecast by Application (2021-2026)
5.2.2 Global Human Coagulation Factor IX Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Coagulation Factor IX Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Coagulation Factor IX by Country
6.1.1 North America Human Coagulation Factor IX Sales by Country
6.1.2 North America Human Coagulation Factor IX Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Coagulation Factor IX Market Facts & Figures by Type
6.3 North America Human Coagulation Factor IX Market Facts & Figures by Application
7 Europe
7.1 Europe Human Coagulation Factor IX by Country
7.1.1 Europe Human Coagulation Factor IX Sales by Country
7.1.2 Europe Human Coagulation Factor IX Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Coagulation Factor IX Market Facts & Figures by Type
7.3 Europe Human Coagulation Factor IX Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Coagulation Factor IX by Region
8.1.1 Asia Pacific Human Coagulation Factor IX Sales by Region
8.1.2 Asia Pacific Human Coagulation Factor IX Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Coagulation Factor IX Market Facts & Figures by Type
8.3 Asia Pacific Human Coagulation Factor IX Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Coagulation Factor IX by Country
9.1.1 Latin America Human Coagulation Factor IX Sales by Country
9.1.2 Latin America Human Coagulation Factor IX Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Coagulation Factor IX Market Facts & Figures by Type
9.3 Central & South America Human Coagulation Factor IX Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Coagulation Factor IX by Country
10.1.1 Middle East and Africa Human Coagulation Factor IX Sales by Country
10.1.2 Middle East and Africa Human Coagulation Factor IX Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Coagulation Factor IX Market Facts & Figures by Type
10.3 Middle East and Africa Human Coagulation Factor IX Market Facts & Figures by Application
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Description and Business Overview
11.1.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Grifols Human Coagulation Factor IX Products Offered
11.1.5 Grifols Related Developments
11.2 Biogen
11.2.1 Biogen Corporation Information
11.2.2 Biogen Description and Business Overview
11.2.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biogen Human Coagulation Factor IX Products Offered
11.2.5 Biogen Related Developments
11.3 Octapharma
11.3.1 Octapharma Corporation Information
11.3.2 Octapharma Description and Business Overview
11.3.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Octapharma Human Coagulation Factor IX Products Offered
11.3.5 Octapharma Related Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Description and Business Overview
11.4.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Baxter Human Coagulation Factor IX Products Offered
11.4.5 Baxter Related Developments
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Description and Business Overview
11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer Human Coagulation Factor IX Products Offered
11.5.5 Bayer Related Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Description and Business Overview
11.6.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.6.4 CSL Human Coagulation Factor IX Products Offered
11.6.5 CSL Related Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Corporation Information
11.7.2 Novo Nordisk Description and Business Overview
11.7.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novo Nordisk Human Coagulation Factor IX Products Offered
11.7.5 Novo Nordisk Related Developments
11.8 Greencross
11.8.1 Greencross Corporation Information
11.8.2 Greencross Description and Business Overview
11.8.3 Greencross Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Greencross Human Coagulation Factor IX Products Offered
11.8.5 Greencross Related Developments
11.9 Kedrion
11.9.1 Kedrion Corporation Information
11.9.2 Kedrion Description and Business Overview
11.9.3 Kedrion Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Kedrion Human Coagulation Factor IX Products Offered
11.9.5 Kedrion Related Developments
11.10 BPL
11.10.1 BPL Corporation Information
11.10.2 BPL Description and Business Overview
11.10.3 BPL Sales, Revenue and Gross Margin (2015-2020)
11.10.4 BPL Human Coagulation Factor IX Products Offered
11.10.5 BPL Related Developments
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Description and Business Overview
11.1.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Grifols Human Coagulation Factor IX Products Offered
11.1.5 Grifols Related Developments
11.12 RAAS
11.12.1 RAAS Corporation Information
11.12.2 RAAS Description and Business Overview
11.12.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
11.12.4 RAAS Products Offered
11.12.5 RAAS Related Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Description and Business Overview
11.13.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Pfizer Products Offered
11.13.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Coagulation Factor IX Market Estimates and Projections by Region
12.1.1 Global Human Coagulation Factor IX Sales Forecast by Regions 2021-2026
12.1.2 Global Human Coagulation Factor IX Revenue Forecast by Regions 2021-2026
12.2 North America Human Coagulation Factor IX Market Size Forecast (2021-2026)
12.2.1 North America: Human Coagulation Factor IX Sales Forecast (2021-2026)
12.2.2 North America: Human Coagulation Factor IX Revenue Forecast (2021-2026)
12.2.3 North America: Human Coagulation Factor IX Market Size Forecast by Country (2021-2026)
12.3 Europe Human Coagulation Factor IX Market Size Forecast (2021-2026)
12.3.1 Europe: Human Coagulation Factor IX Sales Forecast (2021-2026)
12.3.2 Europe: Human Coagulation Factor IX Revenue Forecast (2021-2026)
12.3.3 Europe: Human Coagulation Factor IX Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Coagulation Factor IX Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Coagulation Factor IX Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Coagulation Factor IX Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Coagulation Factor IX Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Coagulation Factor IX Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Coagulation Factor IX Sales Forecast (2021-2026)
12.5.2 Latin America: Human Coagulation Factor IX Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Coagulation Factor IX Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Coagulation Factor IX Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Coagulation Factor IX Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Coagulation Factor IX Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Coagulation Factor IX Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Coagulation Factor IX Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Coagulation Factor IX Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Coagulation Factor IX Market Segments
Table 2. Ranking of Global Top Human Coagulation Factor IX Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Coagulation Factor IX Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AHGB
Table 5. Major Manufacturers of AHFB
Table 6. Major Manufacturers of Others
Table 7. Global Human Coagulation Factor IX Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Human Coagulation Factor IX Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Human Coagulation Factor IX Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Human Coagulation Factor IX Sales Market Share by Regions (2015-2020)
Table 11. Global Human Coagulation Factor IX Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Human Coagulation Factor IX Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Human Coagulation Factor IX Sales Share by Manufacturers (2015-2020)
Table 14. Global Human Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Human Coagulation Factor IX by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor IX as of 2019)
Table 16. Human Coagulation Factor IX Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Human Coagulation Factor IX Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Human Coagulation Factor IX Price (2015-2020) (USD/Pcs)
Table 19. Human Coagulation Factor IX Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Human Coagulation Factor IX Product Type
Table 21. Date of International Manufacturers Enter into Human Coagulation Factor IX Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Coagulation Factor IX Sales by Type (2015-2020) (K Pcs)
Table 24. Global Human Coagulation Factor IX Sales Share by Type (2015-2020)
Table 25. Global Human Coagulation Factor IX Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Human Coagulation Factor IX Revenue Share by Type (2015-2020)
Table 27. Human Coagulation Factor IX Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Human Coagulation Factor IX Sales by Application (2015-2020) (K Pcs)
Table 29. Global Human Coagulation Factor IX Sales Share by Application (2015-2020)
Table 30. North America Human Coagulation Factor IX Sales by Country (2015-2020) (K Pcs)
Table 31. North America Human Coagulation Factor IX Sales Market Share by Country (2015-2020)
Table 32. North America Human Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Human Coagulation Factor IX Revenue Market Share by Country (2015-2020)
Table 34. North America Human Coagulation Factor IX Sales by Type (2015-2020) (K Pcs)
Table 35. North America Human Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 36. North America Human Coagulation Factor IX Sales by Application (2015-2020) (K Pcs)
Table 37. North America Human Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 38. Europe Human Coagulation Factor IX Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Human Coagulation Factor IX Sales Market Share by Country (2015-2020)
Table 40. Europe Human Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Human Coagulation Factor IX Revenue Market Share by Country (2015-2020)
Table 42. Europe Human Coagulation Factor IX Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Human Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 44. Europe Human Coagulation Factor IX Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Human Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Human Coagulation Factor IX Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Human Coagulation Factor IX Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Human Coagulation Factor IX Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Human Coagulation Factor IX Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Human Coagulation Factor IX Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Human Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Human Coagulation Factor IX Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Human Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 54. Latin America Human Coagulation Factor IX Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Human Coagulation Factor IX Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Human Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Human Coagulation Factor IX Revenue Market Share by Country (2015-2020)
Table 58. Latin America Human Coagulation Factor IX Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Human Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 60. Latin America Human Coagulation Factor IX Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Human Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Human Coagulation Factor IX Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Human Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Human Coagulation Factor IX Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Human Coagulation Factor IX Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Human Coagulation Factor IX Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 70. Grifols Corporation Information
Table 71. Grifols Description and Major Businesses
Table 72. Grifols Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Grifols Product
Table 74. Grifols Recent Development
Table 75. Biogen Corporation Information
Table 76. Biogen Description and Major Businesses
Table 77. Biogen Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Biogen Product
Table 79. Biogen Recent Development
Table 80. Octapharma Corporation Information
Table 81. Octapharma Description and Major Businesses
Table 82. Octapharma Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Octapharma Product
Table 84. Octapharma Recent Development
Table 85. Baxter Corporation Information
Table 86. Baxter Description and Major Businesses
Table 87. Baxter Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Baxter Product
Table 89. Baxter Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Major Businesses
Table 92. Bayer Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Bayer Product
Table 94. Bayer Recent Development
Table 95. CSL Corporation Information
Table 96. CSL Description and Major Businesses
Table 97. CSL Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. CSL Product
Table 99. CSL Recent Development
Table 100. Novo Nordisk Corporation Information
Table 101. Novo Nordisk Description and Major Businesses
Table 102. Novo Nordisk Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Novo Nordisk Product
Table 104. Novo Nordisk Recent Development
Table 105. Greencross Corporation Information
Table 106. Greencross Description and Major Businesses
Table 107. Greencross Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Greencross Product
Table 109. Greencross Recent Development
Table 110. Kedrion Corporation Information
Table 111. Kedrion Description and Major Businesses
Table 112. Kedrion Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Kedrion Product
Table 114. Kedrion Recent Development
Table 115. BPL Corporation Information
Table 116. BPL Description and Major Businesses
Table 117. BPL Human Coagulation Factor IX Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. BPL Product
Table 119. BPL Recent Development
Table 120. Hualan Bio Corporation Information
Table 121. Hualan Bio Description and Major Businesses
Table 122. Hualan Bio Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Hualan Bio Product
Table 124. Hualan Bio Recent Development
Table 125. RAAS Corporation Information
Table 126. RAAS Description and Major Businesses
Table 127. RAAS Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. RAAS Product
Table 129. RAAS Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Major Businesses
Table 132. Pfizer Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Pfizer Product
Table 134. Pfizer Recent Development
Table 135. Global Human Coagulation Factor IX Sales Forecast by Regions (2021-2026) (K Pcs)
Table 136. Global Human Coagulation Factor IX Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Human Coagulation Factor IX Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Human Coagulation Factor IX Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Human Coagulation Factor IX Sales Forecast by Country (2021-2026) (K Pcs)
Table 140. North America: Human Coagulation Factor IX Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Human Coagulation Factor IX Sales Forecast by Country (2021-2026) (K Pcs)
Table 142. Europe: Human Coagulation Factor IX Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Human Coagulation Factor IX Sales Forecast by Region (2021-2026) (K Pcs)
Table 144. Asia Pacific: Human Coagulation Factor IX Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Human Coagulation Factor IX Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Latin America: Human Coagulation Factor IX Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Human Coagulation Factor IX Sales Forecast by Country (2021-2026) (K Pcs)
Table 148. Middle East and Africa: Human Coagulation Factor IX Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Human Coagulation Factor IX Players
Table 153. Human Coagulation Factor IX Customers List
Table 154. Human Coagulation Factor IX Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor IX Product Picture
Figure 2. Global Human Coagulation Factor IX Sales Market Share by Type in 2020 & 2026
Figure 3. AHGB Product Picture
Figure 4. AHFB Product Picture
Figure 5. Others Product Picture
Figure 6. Global Human Coagulation Factor IX Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Personal Clinic
Figure 9. Others
Figure 10. Human Coagulation Factor IX Report Years Considered
Figure 11. Global Human Coagulation Factor IX Market Size 2015-2026 (US$ Million)
Figure 12. Global Human Coagulation Factor IX Sales 2015-2026 (K Pcs)
Figure 13. Global Human Coagulation Factor IX Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Human Coagulation Factor IX Sales Market Share by Region (2015-2020)
Figure 15. Global Human Coagulation Factor IX Sales Market Share by Region in 2019
Figure 16. Global Human Coagulation Factor IX Revenue Market Share by Region (2015-2020)
Figure 17. Global Human Coagulation Factor IX Revenue Market Share by Region in 2019
Figure 18. Global Human Coagulation Factor IX Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Human Coagulation Factor IX Revenue in 2019
Figure 20. Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Human Coagulation Factor IX Sales Market Share by Type (2015-2020)
Figure 22. Global Human Coagulation Factor IX Sales Market Share by Type in 2019
Figure 23. Global Human Coagulation Factor IX Revenue Market Share by Type (2015-2020)
Figure 24. Global Human Coagulation Factor IX Revenue Market Share by Type in 2019
Figure 25. Global Human Coagulation Factor IX Market Share by Price Range (2015-2020)
Figure 26. Global Human Coagulation Factor IX Sales Market Share by Application (2015-2020)
Figure 27. Global Human Coagulation Factor IX Sales Market Share by Application in 2019
Figure 28. Global Human Coagulation Factor IX Revenue Market Share by Application (2015-2020)
Figure 29. Global Human Coagulation Factor IX Revenue Market Share by Application in 2019
Figure 30. North America Human Coagulation Factor IX Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Human Coagulation Factor IX Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Human Coagulation Factor IX Sales Market Share by Country in 2019
Figure 33. North America Human Coagulation Factor IX Revenue Market Share by Country in 2019
Figure 34. U.S. Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Human Coagulation Factor IX Market Share by Type in 2019
Figure 39. North America Human Coagulation Factor IX Market Share by Application in 2019
Figure 40. Europe Human Coagulation Factor IX Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Human Coagulation Factor IX Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Human Coagulation Factor IX Sales Market Share by Country in 2019
Figure 43. Europe Human Coagulation Factor IX Revenue Market Share by Country in 2019
Figure 44. Germany Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Human Coagulation Factor IX Market Share by Type in 2019
Figure 55. Europe Human Coagulation Factor IX Market Share by Application in 2019
Figure 56. Asia Pacific Human Coagulation Factor IX Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Human Coagulation Factor IX Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Human Coagulation Factor IX Sales Market Share by Region in 2019
Figure 59. Asia Pacific Human Coagulation Factor IX Revenue Market Share by Region in 2019
Figure 60. China Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Human Coagulation Factor IX Market Share by Type in 2019
Figure 83. Asia Pacific Human Coagulation Factor IX Market Share by Application in 2019
Figure 84. Latin America Human Coagulation Factor IX Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Human Coagulation Factor IX Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Human Coagulation Factor IX Sales Market Share by Country in 2019
Figure 87. Latin America Human Coagulation Factor IX Revenue Market Share by Country in 2019
Figure 88. Mexico Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Human Coagulation Factor IX Market Share by Type in 2019
Figure 95. Latin America Human Coagulation Factor IX Market Share by Application in 2019
Figure 96. Middle East and Africa Human Coagulation Factor IX Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Human Coagulation Factor IX Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Human Coagulation Factor IX Revenue Market Share by Country in 2019
Figure 100. Turkey Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Human Coagulation Factor IX Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Human Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Human Coagulation Factor IX Market Share by Type in 2019
Figure 107. Middle East and Africa Human Coagulation Factor IX Market Share by Application in 2019
Figure 108. North America Human Coagulation Factor IX Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Human Coagulation Factor IX Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Human Coagulation Factor IX Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Human Coagulation Factor IX Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Human Coagulation Factor IX Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Human Coagulation Factor IX Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Human Coagulation Factor IX Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Human Coagulation Factor IX Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Human Coagulation Factor IX Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Human Coagulation Factor IX Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
ヒト凝固因子IVの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IV Market The global Human Coagulation Factor IV market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IV Scope and Market Size Human Coa…- 凝固XI因子の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor XI Market The global Coagulation Factor XI market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor XI Scope and Market Size Coagulation Factor XI marke…
- 凝固因子濃縮物の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor Concentrates Market The global Coagulation Factor Concentrates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor Concentrates Scope and Market Si…
- 組換え凝固因子の世界市場（～2026年） Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents. Market Analysis and Insights: Global Recomb…
- 分散型/ POC凝固検査の世界市場（～2026年） Cardiovascular diseases present a wide range of blood disorders (haemostasis) that influences the development cardiovascular co morbidities. Patients exhibiting such symptoms are often prescribed on anti-thrombotic medications to prevent the onset of adverse cardiovascular events arising as a result…